Unica Farma, Lda. Pharmaceutical Import Profile — Angola (DGFT 2022–2026)

Name: Unica Farma, Lda. Pharmaceutical Import Records from India — 5 Products, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unica Farma, Lda. — Pharmaceutical Importer Profile (2026) | 5 Products, $2.0M Trade | TransData Nexus

Unica Farma, Lda.

Pharmaceutical Importer · Angola · Advanced Antibiotics Focus · $2.0M Total Trade · DGFT Verified

Unica Farma, Lda. is a pharmaceutical importer based in Angola with a total trade value of $2.0M across 5 products in 5 therapeutic categories. Based on 41 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Unica Farma, Lda. sources from 1 verified Indian supplier, with Biomatrix Healthcare Private Limited accounting for 100.0% of imports.

Unica Farma, Lda. — Import Portfolio & Supplier Network

Unica Farma, Lda. import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Unica Farma, Lda.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Biomatrix Healthcare Private Limited	$3.1M	208	100.0%

Unica Farma, Lda. sources from 1 verified Indian supplier across 148 distinct formulations. The sourcing is highly concentrated — Biomatrix Healthcare Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Artemether and lumefantrine tablets ph.	$163.1K	5
Paracetamol tablets BP 500MG (acemol)	$132.7K	5
Ibuprofen oral suspension BP 100MG/5ML	$125.5K	5
Enalapril maleate tablets USP 20 MG	$113.8K	5
Metronidazole tablets BP 500MG (topgyl	$113.8K	3
Clindamycin hydrochloride capsules USP	$108.5K	3
Paediatric co-trimoxazole oral	$108.2K	3
Ambroxol hydrochloride syrup 30MG/5ML	$105.7K	3
Cyproheptadine tablets BP 4MG	$105.7K	3
Metformin extended-release tablets USP	$102.8K	3
Enalapril maleate tablets USP 10 MG	$101.9K	4
Artesunte for injection 120MG (ast 120)(as per inv)	$74.8K	2
Multivitamin caplets (cyproplex plus) (as per inv)	$61.1K	2
Phenoxymethylpenicillin tablets BP	$53.1K	2
Amoxicillin oral suspension BP 250MG /	$50.3K	2

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Metronidazole	Advanced Antibiotics	$750.0K	15	0.4%	7
2	Clindamycin	Antibiotics	$550.0K	11	0.6%	17
3	Enalapril	Cardiovascular	$500.0K	10	0.2%	7
4	Ambroxol	Respiratory & OTC	$150.0K	3	1.0%	3
5	Ibuprofen Paracetamol	Combination Drugs	$11.3K	2	0.6%	9

Unica Farma, Lda. imports 5 pharmaceutical products across 5 categories into Angola totaling $2.0M.

Unica Farma, Lda. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Unica Farma, Lda. is a private pharmaceutical importer and wholesaler based in Luanda, Angola. Established in 2016, the company is committed to enhancing public health by providing quality pharmaceutical products. Operating under the ISIC code 464, which pertains to wholesale trade of household goods, Unica Farma, Lda. plays a pivotal role in Angola's pharmaceutical distribution network.

The company's headquarters are situated at Avenida Pedro De Castro Van-Dúnem Loy, Bairro Palanca, Municipio Kilamba Kiaxi, Luanda, Angola. Additionally, Unica Farma, Lda. maintains a distribution center at Estrada Direita De Cacuaco, Km 4, 5 Talhao No.251/H, Municipio de Luanda, Angola. These facilities enable the company to effectively manage its operations and serve the Angolan market.

2Distribution Network

Unica Farma, Lda. operates two primary facilities in Luanda, Angola:

Central Warehouse (Palanca): Located at Avenida Pedro De Castro Van-Dúnem Loy, Bairro Palanca, Municipio Kilamba Kiaxi, Luanda, this facility serves as the main distribution hub.

Secondary Warehouse (Mulemba): Situated at Estrada Direita De Cacuaco, Km 4, 5 Talhao No.251/H, Municipio de Luanda, this warehouse supports the company's logistics operations.

These strategically positioned warehouses enable Unica Farma, Lda. to efficiently distribute pharmaceutical products across Angola, ensuring timely delivery to various healthcare providers and retailers.

3Industry Role

Unica Farma, Lda. functions as a primary wholesaler in Angola's pharmaceutical supply chain. By importing finished pharmaceutical formulations from India, the company bridges the gap between international manufacturers and the local market. This role is crucial in ensuring the availability of essential medications throughout Angola.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Unica Farma, Lda.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Unica Farma, Lda. demonstrates a high degree of supplier concentration, sourcing 100% of its pharmaceutical imports from a single Indian supplier, BIOMATRIX HEALTHCARE PRIVATE LIMITED. This exclusive sourcing strategy may offer benefits such as streamlined logistics and potentially favorable pricing. However, it also exposes the company to risks associated with supplier dependency, including potential disruptions in supply due to unforeseen events affecting the supplier. The stability of this relationship is critical for Unica Farma, Lda.'s operations, and any instability could significantly impact the company's ability to meet market demand.

2Supply Chain Resilience

The resilience of Unica Farma, Lda.'s supply chain is closely tied to the stability of its sole supplier, BIOMATRIX HEALTHCARE PRIVATE LIMITED. The lack of alternative suppliers for the imported formulations increases the company's vulnerability to supply chain disruptions. Additionally, the company's focus on a limited range of formulations may restrict its ability to adapt to changing market demands or regulatory requirements. To enhance supply chain resilience, Unica Farma, Lda. could consider diversifying its supplier base and expanding its product portfolio.

Strategic Implications

Importing Pharmaceuticals into Angola — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Angola

1Regulatory Authority & Framework

The pharmaceutical sector in Angola is regulated by the Regulatory Agency for Medicines and Healthcare Technologies (ARMED), operating under the Ministry of Health. ARMED is responsible for licensing pharmaceutical products, ensuring quality control, and overseeing the importation of healthcare products. The General Law of Medicines and Medical Devices (2019) establishes guidelines for the regulation of medicines and medical devices in Angola, including importation procedures.

2Import Licensing & GMP

Importers of pharmaceutical products for human use in Angola must obtain licenses from the Ministry of Health. These licenses are granted to approved importers, who are permitted to import healthcare products directly from overseas manufacturers. The licensing process is governed by Presidential Decree No. 202/21 of 26 August 2021, which aims to streamline the procedures for engaging in pharmaceutical activities.

3Quality & Labeling

Imported pharmaceutical products must comply with quality standards set by ARMED. This includes ensuring that products are approved by internationally recognized health authorities, such as the World Health Organization (WHO), the European Medicines Agency (EMA), or the Food and Drug Administration (FDA) of the United States. Additionally, products must meet labeling requirements, including batch testing, stability requirements, and language specifications. Specific labeling language requirements and serialization mandates are determined by ARMED to ensure clarity and traceability of pharmaceutical products.

Unica Farma, Lda. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Unica Farma, Lda. focuses on importing finished pharmaceutical formulations across five therapeutic categories, with a significant emphasis on Advanced Antibiotics (38.2%), Antibiotics (28.0%), and Cardiovascular (25.5%). This strategic focus aligns with the prevalent health challenges in Angola, where infectious diseases and cardiovascular conditions are common. The company's product mix is tailored to meet the therapeutic needs of the Angolan population, addressing critical health concerns effectively.

2Sourcing Profile

Unica Farma, Lda. primarily sources generic pharmaceutical formulations from India, with a portfolio of 148 unique formulations. The company's exclusive sourcing from a single supplier, BIOMATRIX HEALTHCARE PRIVATE LIMITED, suggests a strategic choice to maintain consistency and quality in its product offerings. This approach may also facilitate streamlined logistics and potentially favorable pricing arrangements.

3Market Positioning

By focusing on essential therapeutic areas such as Advanced Antibiotics, Antibiotics, and Cardiovascular medications, Unica Farma, Lda. positions itself to serve a broad segment of the Angolan healthcare market. The company's product offerings are likely distributed through various channels, including retail pharmacies, hospitals, and government tenders, ensuring widespread availability of critical medications.

Seller's Guide — How to Become a Supplier to Unica Farma, Lda.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a potential opportunity for new Indian suppliers to collaborate with Unica Farma, Lda., provided they can meet the company's quality standards and regulatory requirements. Diversifying the supplier base could mitigate risks associated with supplier dependency and enhance the company's resilience. Additionally, expanding the product portfolio to include a broader range of therapeutic areas could address unmet medical needs in Angola and strengthen Unica Farma, Lda.'s market position.

2Requirements & Qualifications

Indian exporters seeking to supply Unica Farma, Lda. must ensure that their products are approved by internationally recognized health authorities, such as the WHO, EMA, or FDA. Compliance with ARMED's quality standards, including batch testing and stability requirements, is essential. Additionally, products must meet labeling requirements, including language specifications and serialization mandates, as determined by ARMED. Obtaining the necessary import licenses from the Ministry of Health is a prerequisite for engaging in pharmaceutical activities in Angola.

3How to Approach

Frequently Asked Questions — Unica Farma, Lda.

What products does Unica Farma, Lda. import from India?

Unica Farma, Lda. imports 5 pharmaceutical products across 5 categories. Top imports: Metronidazole ($750.0K), Clindamycin ($550.0K), Enalapril ($500.0K), Ambroxol ($150.0K), Ibuprofen Paracetamol ($11.3K).

Who supplies pharmaceuticals to Unica Farma, Lda. from India?

Unica Farma, Lda. sources from 1 verified Indian suppliers. The primary supplier is Biomatrix Healthcare Private Limited (100.0% of imports, $3.1M).

What is Unica Farma, Lda.'s total pharmaceutical import value?

Unica Farma, Lda.'s total pharmaceutical import value from India is $2.0M, based on 41 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Unica Farma, Lda. focus on?

Unica Farma, Lda. imports across 5 categories. The largest: Advanced Antibiotics (38.2%), Antibiotics (28.0%), Cardiovascular (25.5%).

Get Full Unica Farma, Lda. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.